Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 May;29(5):938–940. doi: 10.1128/aac.29.5.938

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

P A Colaizzi, R E Polk, W J Poynor, A C Raffalovich, E A Cefali, L A Beightol
PMCID: PMC284187  PMID: 3729353

Abstract

The single-dose pharmacokinetics of azlocillin and piperacillin were compared by using a randomized, crossover design. The concentrations of azlocillin in serum were consistently higher than those of piperacillin throughout an 8-h study. The area under the time-concentration curve of azlocillin was significantly greater than that of piperacillin, and the total body clearance of azlocillin was significantly lower than that of piperacillin.

Full text

PDF
938

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batra V. K., Morrison J. A., Lasseter K. C., Joy V. A. Piperacillin kinetics. Clin Pharmacol Ther. 1979 Jul;26(1):41–53. doi: 10.1002/cpt197926141. [DOI] [PubMed] [Google Scholar]
  2. Bergan T. Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency. J Antimicrob Chemother. 1983 May;11 (Suppl B):101–114. doi: 10.1093/jac/11.suppl_b.101. [DOI] [PubMed] [Google Scholar]
  3. Bergan T., Williams J. D. Dose dependence of piperacillin pharmacokinetics. Chemotherapy. 1982;28(3):153–159. doi: 10.1159/000238070. [DOI] [PubMed] [Google Scholar]
  4. Brisson A. M., Fourtillan J. B. High-performance liquid chromatographic determination of piperacillin in plasma. Antimicrob Agents Chemother. 1982 Apr;21(4):664–665. doi: 10.1128/aac.21.4.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drusano G. L., Schimpff S. C., Hewitt W. L. The acylampicillins: mezlocillin, piperacillin, and azlocillin. Rev Infect Dis. 1984 Jan-Feb;6(1):13–32. doi: 10.1093/clinids/6.1.13. [DOI] [PubMed] [Google Scholar]
  6. Eliopoulos G. M., Moellering R. C., Jr Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins. Ann Intern Med. 1982 Nov;97(5):755–760. doi: 10.7326/0003-4819-97-5-755. [DOI] [PubMed] [Google Scholar]
  7. Evans M. A., Wilson P., Leung T., Williams J. D. Pharmacokinetics of piperacillin following intravenous administration. J Antimicrob Chemother. 1978 May;4(3):255–261. doi: 10.1093/jac/4.3.255. [DOI] [PubMed] [Google Scholar]
  8. Gillett A. P. Antibiotics against Pseudomonas. J Antimicrob Chemother. 1982 Feb;9 (Suppl B):41–48. doi: 10.1093/jac/9.suppl_b.41. [DOI] [PubMed] [Google Scholar]
  9. Leroy A., Humbert G., Fillastre J. P. Pharmacokinetics of azlocillin in healthy subjects. Scand J Infect Dis Suppl. 1981;29:49–54. [PubMed] [Google Scholar]
  10. Leroy A., Humbert G., Godin M., Fillastre J. P. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function. Antimicrob Agents Chemother. 1980 Mar;17(3):344–349. doi: 10.1128/aac.17.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. O'Callaghan C. H., Acred P., Harper P. B., Ryan D. M., Kirby S. M., Harding S. M. GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother. 1980 May;17(5):876–883. doi: 10.1128/aac.17.5.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tjandramaga T. B., Mullie A., Verbesselt R., De Schepper P. J., Verbist L. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration. Antimicrob Agents Chemother. 1978 Dec;14(6):829–837. doi: 10.1128/aac.14.6.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Verbist L. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms. Antimicrob Agents Chemother. 1979 Aug;16(2):115–119. doi: 10.1128/aac.16.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Welling P. G., Craig W. A., Bundtzen R. W., Kwok F. W., Gerber A. U., Madsen P. O. Pharmacokinetics of piperacillin in subjects with various degrees of renal function. Antimicrob Agents Chemother. 1983 Jun;23(6):881–887. doi: 10.1128/aac.23.6.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wise R., Andrews J. M., Bedford K. A. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs. Antimicrob Agents Chemother. 1978 Oct;14(4):549–552. doi: 10.1128/aac.14.4.549. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES